Navigation Links
deCODE genetics to Webcast Presentation at Piper Jaffray Europe Conference
Date:6/19/2008

REYKJAVIK, Iceland, June 19 /PRNewswire-FirstCall/ -- deCODE genetics (Nasdaq: DCGN) today announced that it will host a live webcast of deCODE CEO Kari Stefansson's presentation at the Piper Jaffray Europe Conference.

The presentation will be delivered on Wednesday, June 25, at 7am Eastern Time/11am GMT/12 noon British Summer time, at the ANdAZ hotel in London. The webcast can be accessed through the Investors page on deCODE's website, http://www.decode.com, and those interested in listening should log on a few minutes in advance in order to download any software or complete any sign-in that may be required. The webcast will be archived for at least one week.

About deCODE

deCODE is a biopharmaceutical company applying its discoveries in human genetics to the development of diagnostics and drugs for common diseases. deCODE is a global leader in gene discovery - our population approach and resources have enabled us to isolate key genes contributing to major public health challenges from cardiovascular disease to cancer, genes that are providing us with drug targets rooted in the basic biology of disease. Through its CLIA-registered laboratory, deCODE is offering a growing range of DNA-based tests for gauging risk and empowering prevention of common diseases, including deCODE T2(TM) for type 2 diabetes; deCODE AF(TM) for atrial fibrillation and stroke; deCODE MI(TM) for heart attack; deCODE ProCa(TM) for prostate cancer; and deCODE Glaucoma(TM) for a major type of glaucoma. deCODE is delivering on the promise of the new genetics.(SM) Visit us on the web at http://www.decode.com; on our diagnostics website at

SOURCE deCODE genetics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. deCODE genetics Announces First Quarter 2008 Financial Results
2. deCODE Discovers Fourth Major Set of Common Genetic Variants Linked to Risk of Estrogen Receptor-Positive Breast Cancer
3. deCODE Lauds Federal Legislation to Ban Discrimination on the Basis of Genetic Information
4. deCODE genetics Announces Webcast of Conference Call to Discuss First Quarter 2008 Financial Results
5. U.S. Preventive Medicine and deCODE Genetics Sign Letter of Intent to Expand Personalized Medicine Platform
6. A Smoking Gene: deCODE Shows How a Single Variant in the Sequence of the Genome Confers Nicotine Dependence and Risk of Lung Cancer and Other Disease
7. deCODE genetics to Webcast Presentation at 15th Annual Future Leaders in the Biotech Industry Conference
8. deCODE genetics to Webcast Presentation at Lehman Brothers Eleventh Annual Global Healthcare Conference
9. deCODE Genetics Announces Full-year 2007 Financial Results
10. deCODE genetics Announces Webcast of Conference Call to Discuss Full-year 2007 Financial Results
11. deCODE genetics to Webcast Presentation at BIO CEO and Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):Study finds new relationship between gene duplication and alternative splicing in plants 2Study finds new relationship between gene duplication and alternative splicing in plants 3Self-destructing bacteria improve renewable biofuel production 2Self-destructing bacteria improve renewable biofuel production 3Spices halt growth of breast stem cells, U-M study finds 2Breaking medical and scientific news in angioplasty to be presented in San Francisco at TCT 2009 49237 1BurrellesLuce Executive to Speak on Measuring Communications Impact At Joint Seminar of Port Industry Group and PRSA 26apos 3Bs Detroit Chapter 49235 1BurrellesLuce Executive to Speak on Measuring Communications Impact At Joint Seminar of Port Industry Group and PRSA 26apos 3Bs Detroit Chapter 49235 2BurrellesLuce Executive to Speak on Measuring Communications Impact At Joint Seminar of Port Industry Group and PRSA 26apos 3Bs Detroit Chapter 49235 3BBK Worldwide Foresees Expanding Global Demand for Patient Recruitment Technology 49232 1BBK Worldwide Foresees Expanding Global Demand for Patient Recruitment Technology 49232 2BBK Worldwide Foresees Expanding Global Demand for Patient Recruitment Technology 49232 3BBK Worldwide Foresees Expanding Global Demand for Patient Recruitment Technology 49232 4